UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)

UPWARDS 培训计划(代表性不足的少数族裔致力于科学研究多样性)

基本信息

  • 批准号:
    10023785
  • 负责人:
  • 金额:
    $ 41.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-03 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT As a recognized leader in cancer research,1 MD Anderson Cancer Center is well poised to address a significant lack of diversity in the cancer research workforce that contributes to considerable disparities.2-6 We will do so via early intervention programs that foster sustained interest in cancer research in students underrepresented and minority in Science (URMS). Since 2011, we have directed a summer undergraduate training program encompassing 345 trainees (from 2011-2018), including 120 URMS. Significantly, outcomes for URMS and non-minority trainees in our program are indistinguishable; URMS and non-minority alumni are enrolled in or have completed STEM bachelor’s (98.8% vs 98.1%) and doctoral (both 67.1%) degrees and are retained in STEM education or workforce (98.3% vs 98.6%, respectively). Built upon these successes, we have designed a comprehensive cancer research training program for high school and undergraduate URMS via the R25 YES initiative. In our URMS-focused program, we address major barriers in URMS pursuit and success in STEM, including: limited 1) research experience, 2) career path knowledge, and 3) scientific identity formation and exposure to science; 4) underdeveloped professionalism and communication skills; 5) inadequate research, educational, and career mentoring; and 6) barriers in the graduate application process. Our proposed UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science) has 3 tracks: full-time, 12-week summer research for 1) high-schoolers and 2) undergraduates and 3) part-time, 40-week research for undergraduates. Within each track, we propose the following aims to address the aforementioned barriers: Aim 1) Employ focused URMS recruitment and holistic strategies for program inclusion, and deliver didactic learning and hands-on cancer research experiences through a cadre of outstanding mentoring faculty. Aim 2) Develop and deliver individualized mentoring, career exploration, and professional development that stimulates graduate education and cancer research career pursuit. Aim 3) Educate and inspire URMS communities, young generations in the STEM pipeline, and the families and support systems of our students through training, STEM outreach, and hands-on engagement. We will encourage our trainees to lead and encourage their communities and younger generations through hands-on STEM outreach activities and design and delivery of community education. Aim 4) Implement and maintain a rigorous assessment program with continual appraisal and enactment of novel, evidence-driven best practices derived from these efforts. Lastly, we commit to disseminating our findings and best practices via peer-reviewed publications. Through the UPWARDS Program, we will build upon our prior experiences and best practices to launch a cancer research training program specifically designed to fit the needs of URMS trainees in our local community and nationally. We anticipate our efforts will effectively increase diversity in the STEM educational pipeline and cancer research workforce.
项目概要/摘要 作为癌症研究领域公认的领导者1,MD 安德森癌症中心已做好准备解决以下问题: 癌症研究队伍严重缺乏多样性,这导致了巨大的差异。2-6 我们 将通过早期干预计划来实现这一目标,以培养学生对癌症研究的兴趣 自 2011 年起,我们就开设了一个暑期本科生项目。 培训计划涵盖 345 名学员(2011 年至 2018 年),其中 120 名 URMS。 对于我们项目中的 URMS 和非少数族裔学员来说,URMS 和非少数族裔校友是无法区分的; 已注册或已完成 STEM 学士学位(98.8% vs 98.1%)和博士学位(均为 67.1%) 保留在 STEM 教育或劳动力中(分别为 98.3% 和 98.6%)。 通过 URMS 为高中和本科生设计了全面的癌症研究培训计划 R25 YES 计划在我们以 URMS 为重点的计划中,我们解决了 URMS 追求和成功的主要障碍。 STEM,包括:有限的 1) 研究经验,2) 职业道路知识,以及 3) 科学身份形成 和接触科学; 4) 专业精神和沟通能力不足; 研究、教育和职业指导;6) 研究生申请过程中的障碍。 拟议的 UPWARDS 培训计划(代表性不足的少数族裔致力于研究多样性 Science)有 3 个方向:全日制、为期 12 周的暑期研究,对象为 1) 高中生和 2) 本科生和 3) 在每个方向中,我们为本科生提供为期 40 周的兼职研究,以解决以下问题。 上述内容:目标 1) 针对项目采用有针对性的 URMS 障碍和整体策略 包容性,并通过骨干人员提供教学学习和实践癌症研究经验 目标 2) 发展并提供个性化指导、职业探索、 刺激研究生教育和癌症研究职业追求的专业发展。 目标 3) 教育和激励 URMS 社区、STEM 领域的年轻一代以及 通过培训、STEM 推广和实践,为学生的家庭和支持系统提供支持 我们将鼓励学员领导和鼓励他们的社区和年轻人。 通过实践 STEM 外展活动以及社区教育的设计和实施,一代又一代的人参与其中。 目标 4) 实施并维持严格的评估计划,持续评估和制定 最后,我们致力于传播我们的成果。 通过同行评审的出版物,我们将建立调查结果和最佳实践。 根据我们之前的经验和最佳实践,专门启动了癌症研究培训计划 旨在满足我们当地社区和全国范围内 URMS 学员的需求,我们预计我们的努力将会实现。 有效增加 STEM 教育渠道和癌症研究队伍的多样性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KHANDAN KEYOMARSI其他文献

KHANDAN KEYOMARSI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KHANDAN KEYOMARSI', 18)}}的其他基金

Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
靶向 STAT3 治疗 CDK4/6 抑制剂耐药的晚期雌激素受体阳性乳腺癌患者
  • 批准号:
    10316167
  • 财政年份:
    2020
  • 资助金额:
    $ 41.96万
  • 项目类别:
UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
UPWARDS 培训计划(代表性不足的少数族裔致力于科学研究多样性)
  • 批准号:
    10252909
  • 财政年份:
    2020
  • 资助金额:
    $ 41.96万
  • 项目类别:
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
靶向 STAT3 治疗 CDK4/6 抑制剂耐药的晚期雌激素受体阳性乳腺癌患者
  • 批准号:
    10097489
  • 财政年份:
    2020
  • 资助金额:
    $ 41.96万
  • 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
  • 批准号:
    10550153
  • 财政年份:
    2018
  • 资助金额:
    $ 41.96万
  • 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
  • 批准号:
    9436336
  • 财政年份:
    2018
  • 资助金额:
    $ 41.96万
  • 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
  • 批准号:
    10337331
  • 财政年份:
    2018
  • 资助金额:
    $ 41.96万
  • 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
  • 批准号:
    10113558
  • 财政年份:
    2018
  • 资助金额:
    $ 41.96万
  • 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
  • 批准号:
    8250334
  • 财政年份:
    2011
  • 资助金额:
    $ 41.96万
  • 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
  • 批准号:
    8631060
  • 财政年份:
    2011
  • 资助金额:
    $ 41.96万
  • 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
  • 批准号:
    8454512
  • 财政年份:
    2011
  • 资助金额:
    $ 41.96万
  • 项目类别:

相似海外基金

The Syracuse University-Summer Training in Alcohol Research (SU-STAR) Program
雪城大学酒精研究夏季培训 (SU-STAR) 计划
  • 批准号:
    10594142
  • 财政年份:
    2023
  • 资助金额:
    $ 41.96万
  • 项目类别:
Understanding the relationship between nurse staffing and outcomes: impact of individual nurse education, expertise, and effort level on individual patient outcomes
了解护士人员配置与结果之间的关系:护士个体教育、专业知识和努力水平对个体患者结果的影响
  • 批准号:
    10642570
  • 财政年份:
    2023
  • 资助金额:
    $ 41.96万
  • 项目类别:
Generating Research Opportunities Within Statistics at Fred Hutch (GROWS@FredHutch)
在 Fred Hutch 的统计领域创造研究机会 (GROWS@FredHutch)
  • 批准号:
    10627415
  • 财政年份:
    2023
  • 资助金额:
    $ 41.96万
  • 项目类别:
Post-Baccalaureate Research and Education Program (PREP) for Oklahoma
俄克拉荷马州学士后研究与教育计划 (PREP)
  • 批准号:
    10556953
  • 财政年份:
    2023
  • 资助金额:
    $ 41.96万
  • 项目类别:
VT-ESTEEMED
VT-尊崇
  • 批准号:
    10653568
  • 财政年份:
    2023
  • 资助金额:
    $ 41.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了